Insider trades by month
US insider trades, September 2024
The 10,511 open-market buys and sales by US company CEOs, executives and directors filed in September 2024.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Carl J. ChaneyDirector | MidWestOne Financial Group | Open-market buy | 24/09/30 | 24/09/30 | 6,000 sh | $25.00 | $150,000 | +451.8% |
Director | HagertyHGTY | Open-market sale10b5-1 plan | 24/09/26–24/09/30 | 24/09/30 | 14,253 sh3 trades | $10.38avg. | $147,944.58 | −0.3% |
Douglas H. GreeffDirector | MidWestOne Financial Group | Open-market buy | 24/09/30 | 24/09/30 | 4,000 sh | $25.00 | $100,000 | +40.4% |
Kellogg W K Foundation10% Owner | Kellanova | Open-market sale10b5-1 plan | 24/09/30 | 24/09/30 | 114,583 sh | $80.72 | $9,249,139.76 | −0.2% |
Kellogg W. K. Foundation Trust10% Owner | Kellanova | Open-market sale10b5-1 plan | 24/09/30 | 24/09/30 | 114,583 sh | $80.72 | $9,249,139.76 | −0.2% |
MatsonMATX | Open-market sale10b5-1 plan | 24/09/30 | 24/09/30 | 6,499 sh3 trades | $143.82avg. | $934,688.31 | −3.0% | |
Full House ResortsFLL | Open-market sale10b5-1 plan | 24/09/26–24/09/30 | 24/09/30 | 9,604 sh3 trades | $5.03avg. | $48,327.83 | −0.6% | |
Larry D. AlbertDirector | MidWestOne Financial Group | Open-market buy | 24/09/30 | 24/09/30 | 600 sh | $25.00 | $15,000 | +3.5% |
Brian J. CaliChairman | Fidelity D & D BancorpFDBC | Open-market buy | 24/09/30 | 24/09/30 | 212.98 sh | $54.15 | $11,532.87 | +0.1% |
Keith BarnesDirector | KnowlesKN | Open-market sale | 24/09/30 | 24/09/30 | 6,725 sh | $17.88 | $120,243 | −7.2% |
Robert I. BlumPresident & CEO | CytokineticsCYTK | Open-market sale10b5-1 plan | 24/09/30 | 24/09/30 | 5,000 sh | $52.14 | $260,700 | −1.2% |
Cantaloupe | Open-market buy | 24/09/26–24/09/30 | 24/09/30 | 284,000 sh3 trades | $7.40avg. | $2,100,834.84 | +159.3% | |
Janux TherapeuticsJANX | Open-market sale | 24/09/26–24/09/30 | 24/09/30 | 307,779 sh14 trades | $46.96avg. | $14,452,393.76 | No record | |
William M. LyonsDirector | MorningstarMORN | Open-market sale10b5-1 plan | 24/09/30 | 24/09/30 | 750 sh | $316.48 | $237,360 | −5.2% |
Inmune BioINMB | Open-market buy | 24/09/30 | 24/09/30 | 10,000 sh | $5.29 | $52,900 | +0.8% | |
Kevin W. MonsonDirector | MidWestOne Financial Group | Open-market buy | 24/09/30 | 24/09/30 | 2,000 sh | $25.00 | $50,000 | +2.1% |
Charles N. FunkDirector | MidWestOne Financial Group | Open-market buy | 24/09/30 | 24/09/30 | 2,240 sh | $25.00 | $56,000 | +1.8% |
Michael K. KorenkoCEO and President | VivosRDGL | Open-market buy | 24/09/30 | 24/09/30 | 50,000 sh | $0.16 | $8,000 | +0.5% |
Jeffrey A. MecklerDirector | Travere TherapeuticsTVTX | Open-market sale10b5-1 plan | 24/09/30 | 24/09/30 | 40,000 sh | $14.06 | $562,400 | −33.1% |
Tracy S. McCormickDirector | MidWestOne Financial Group | Open-market buy | 24/09/30 | 24/09/30 | 2,000 sh | $25.00 | $50,000 | +2.2% |
Other months
- September 20261,500
- June 202620,298
- May 202614,504
- April 20269,432
- March 202614,721
- February 202610,638
- January 20267,844
- December 202512,093
- November 202511,751
- October 202513,072
- September 202513,090
- August 202514,381
- July 20258,748
- June 202511,426
- May 202511,415
- April 20256,792
- March 202512,399
- February 202510,686
- January 20258,151
- December 202416,069
- November 202416,983
- October 20248,518
- September 202410,511
- August 202414,013
- July 202410,847
- June 202412,704
- May 202412,649
- April 20248,608
- March 202417,622
- February 202413,916
- January 20249,748
- December 202314,239
- November 202312,685
- October 20236,365
- September 20239,845
- August 202312,892
- July 20237,232
- June 202311,204
- May 202313,009
- April 20235,870
- March 202313,084
- February 202311,300
- January 20238,626